Home /Research /Rational mutagenesis to support structure-based drug design: MAPKAP kinase 2 as a case study
OTHER

Rational mutagenesis to support structure-based drug design: MAPKAP kinase 2 as a case study

M.A. Argiriadi, Silvino Sousa, David Banach, D.J. Marcotte, Tao Xiang, Medha J. Tomlinson, Megan D. Demers, Christopher M. Harris, Silvia Kwak, Jennifer Hardman, Margaret Pietras, Lisa Quinn, J. Dimauro, Baofu Ni, John A. Mankovich, David W. Borhani, Robert V. Talanian, Ramkrishna Sadhukhan

Year
2009
Citations
11
Access
Open access

Keywords

ChemistryDrug designKinaseDrugMutagenesisCell biologyRational designComputational biologyBiochemistryPharmacology

Related papers

Browse all OTHER papers